Randomized, double-blinded, placebo-controlled trial of allogeneic cord blood T-regulatory cells for treatment of COVID-19 ARDS

Blood Adv. 2023 Jul 11;7(13):3075-3079. doi: 10.1182/bloodadvances.2022009619.
No abstract available

Publication types

  • Randomized Controlled Trial

MeSH terms

  • COVID-19*
  • Fetal Blood
  • Hematopoietic Stem Cell Transplantation*
  • Humans
  • Respiratory Distress Syndrome* / etiology
  • Respiratory Distress Syndrome* / therapy
  • SARS-CoV-2